BICYCLE THERAPEUTICS PLC — Director's Dealing 2022

Jan 5, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2022-01-03

Reporting Person: Keen Nicholas (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-03	Ordinary Shares	A	15000	$0.00	Acquired	23477	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-03	Employee Stock Option (right to buy)	$60.87	A	30000	Acquired	2032-01-03	Ordinary Shares (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	7000	Indirect

Footnotes

F1: Represents a restricted stock unit ("RSU") award. One-fourth (1/4) of the total number of RSUs shall vest on January 3, 2023 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.

F2: Each RSU represents a contingent right to receive one ordinary share.

F3: This option shall vest one-fourth (1/4) of the total number of shares underlying the option on January 3, 2023 and the remaining shares in 36 equal monthly installments thereafter.